Chouik et al. reported that the combination of a heterozygous apolipoprotein B (APOB) gene mutation with the PNPLA3 and TM6SF2 variants accelerated steatotic liver disease, cirrhosis, and the occurrence of HCC [74]. This evidence concerns the gene PNPLA3 and hepatocellular carcinoma.